Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) represent a powerful cellular platform for illuminating mechanisms of human cardiovascular disease and for pharmacological screening. Recent advances in CRISPR/Cas9-mediated genome editing technology underlie this profound utility. We have generated hiPSC-CMs harboring fluorescently-tagged sarcomeric proteins, which provide a tool to non-invasively study human sarcomere function and dysfunction. In this unit, we illustrate methods for conducting high-efficiency, small molecule-mediated differentiation of hiPSCs into cardiomyocytes, and for performing non-invasive contractile analysis through direct sarcomere tracking of GFP-sarcomere reporter hiPSC-CMs. We believe that this type of analysis can overcome sensitivity problems found in other forms of contractile assays involving hiPSC-CMs by directly measuring contractility at the fundamental contractile unit of the hiPSC-CM, the sarcomere. © 2018 by John Wiley & Sons, Inc.

Original publication

DOI

10.1002/cphg.53

Type

Journal article

Journal

Curr Protoc Hum Genet

Publication Date

24/01/2018

Volume

96

Pages

21.12.1 - 21.12.12

Keywords

CRISPR, cardiomyocytes, contractility, drug screening, fluorescent reporter, iPSCs, pluripotent stem cells, sarcomere, Cell Differentiation, Green Fluorescent Proteins, Humans, Induced Pluripotent Stem Cells, Myocytes, Cardiac, Sarcomeres